BackgroundBreast cancer, particularly invasive carcinoma of no special type (IC NST), demonstrates considerable intratumor morphological heterogeneity. Five types of morphological structures representing different architectural arrangements of tumor cells – tubular, alveolar, trabecular, solid structures, and discrete groups have been described in IC NST. Previous studies reported the contribution of intratumor morphological heterogeneity of IC NST to chemotherapy efficiency and lymph node metastasis (Zavyalova et al., 2013; Denisov et al., 2014); however, its role in distant metastasis remains unidentified. Aim: to study the contribution of intratumor morphological heterogeneity of IC NST to distant metastasis and to identify gene expressi...
Recent studies have highlighted the heterogeneity of the tumor microenvironment (ME) and the importa...
<p>Clusters of circulating tumor cells (CTCs), despite being rare, may account for more than 90% of ...
<p>Clusters of circulating tumor cells (CTCs), despite being rare, may account for more than 90% of ...
BackgroundBreast cancer, particularly invasive carcinoma of no special type (IC NST), demonstrates c...
Intratumoral heterogeneity contributes significantly to the effectiveness of cancer treatment and ou...
Invasive ductal carcinoma (IDC) not otherwise specified (NOS), the most common type of breast cancer...
Aim. To investigate the expression of the genes TGFB1, TNF, CSF1, CSF2, VEGFA and HIF1A in the patie...
In this study, the influence of intratumoral morphological heterogeneity of breast cancer on neoadju...
Intratumor morphological heterogeneity in breast cancer is represented by different morphological st...
Intratumoral heterogeneity contributes significantly to the effectiveness of cancer treatment and ou...
Unlike the great advances that have been made in reducing breast cancer mortality through the multid...
Metastatic disease is the main cause of cancer-related mortality due to almost universal therapeutic...
Metastases have been widely thought to arise from rare, selected, mutation-bearing cells in the prim...
Endocrine therapy is the mainstay of treatment for luminal breast cancer. Despite the widespread suc...
Background: Preclinical drug development studies rarely consider the impact of a candidate drug on e...
Recent studies have highlighted the heterogeneity of the tumor microenvironment (ME) and the importa...
<p>Clusters of circulating tumor cells (CTCs), despite being rare, may account for more than 90% of ...
<p>Clusters of circulating tumor cells (CTCs), despite being rare, may account for more than 90% of ...
BackgroundBreast cancer, particularly invasive carcinoma of no special type (IC NST), demonstrates c...
Intratumoral heterogeneity contributes significantly to the effectiveness of cancer treatment and ou...
Invasive ductal carcinoma (IDC) not otherwise specified (NOS), the most common type of breast cancer...
Aim. To investigate the expression of the genes TGFB1, TNF, CSF1, CSF2, VEGFA and HIF1A in the patie...
In this study, the influence of intratumoral morphological heterogeneity of breast cancer on neoadju...
Intratumor morphological heterogeneity in breast cancer is represented by different morphological st...
Intratumoral heterogeneity contributes significantly to the effectiveness of cancer treatment and ou...
Unlike the great advances that have been made in reducing breast cancer mortality through the multid...
Metastatic disease is the main cause of cancer-related mortality due to almost universal therapeutic...
Metastases have been widely thought to arise from rare, selected, mutation-bearing cells in the prim...
Endocrine therapy is the mainstay of treatment for luminal breast cancer. Despite the widespread suc...
Background: Preclinical drug development studies rarely consider the impact of a candidate drug on e...
Recent studies have highlighted the heterogeneity of the tumor microenvironment (ME) and the importa...
<p>Clusters of circulating tumor cells (CTCs), despite being rare, may account for more than 90% of ...
<p>Clusters of circulating tumor cells (CTCs), despite being rare, may account for more than 90% of ...